Shanghai UniXell Biotechnology Co., Ltd
3 clinical trials · Sponsor
◉ Watch Shanghai UniXell Biotechnology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (NCT07572812) | Shanghai UniXell Biotechnology Co., Ltd | 2026-08-20 |
| Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease (NCT07733349) | Shanghai UniXell Biotechnology Co., Ltd | 2026-08-03 |
| An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease (NCT06778265) | Shanghai UniXell Biotechnology Co., Ltd | 2025-03-01 |
Track Shanghai UniXell Biotechnology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.